Département d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, Hospices Civils de Lyon, Lyon, France; Faculté de médecine Lyon Est, Université Claude Bernard Lyon 1, Lyon, France; CarMeN Laboratory, Inserm UMR 1060, University Claude Bernard Lyon 1, Lyon, Fransce.
Département d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, Hospices Civils de Lyon, Lyon, France; Faculté de médecine Lyon Est, Université Claude Bernard Lyon 1, Lyon, France.
J Cardiothorac Vasc Anesth. 2023 Sep;37(9):1631-1638. doi: 10.1053/j.jvca.2023.04.024. Epub 2023 Apr 23.
The aortic-to-radial arterial pressure gradient is described during and after cardiopulmonary bypass (CPB), and can lead to underestimating arterial blood pressure. The authors hypothesized that central arterial pressure monitoring would be associated with lower norepinephrine requirements than radial arterial pressure monitoring during cardiac surgery.
An observational prospective cohort with propensity score analysis.
At a tertiary academic hospital's operating room and intensive care unit (ICU).
A total of 286 consecutive adult patients undergoing cardiac surgery with CPB (central group: 109; radial group: 177) were enrolled and analyzed.
To explore the hemodynamic effect of the measurement site, the authors divided the cohort into 2 groups according to a femoral/axillary (central group) or radial (radial group) site of arterial pressure monitoring.
The primary outcome was the intraoperative amount of norepinephrine administered. Secondary outcomes included norepinephrine-free hours and ICU-free hours at postoperative day 2 (POD2). A logistic model with propensity score analysis was built to predict central arterial pressure monitoring use. The authors compared demographic, hemodynamic, and outcomes data before and after adjustment. Central group patients had a higher European System for Cardiac Operative Risk Evaluation. (EuroSCORE) compared to the radial group-7.9 ± 14.0 versus 3.8 ± 7.0, p < 0.001. After adjustment, both groups had similar patient EuroSCORE and arterial blood pressure levels. Intraoperative norepinephrine dose regimens were 0.10 ± 0.10 µg/kg/min in the central group and 0.11 ± 0.11 µg/kg/min in the radial group (p = 0.519). Norepinephrine-free hours at POD2 were 38 ± 17 hours versus 33 ± 19 hours in central and radial groups, respectively (p = 0.034). The ICU-free hours at POD2 were greater in the central group: 18 ± 13 hours versus 13 ± 13 hours, p = 0.008. Adverse events were less frequent in the central group than in the radial group-67% versus 50%, p = 0.007.
No differences in the norepinephrine dose regimen were found according to the arterial measurement site during cardiac surgery. However, norepinephrine use and length of stay in the ICU were shorter, and adverse events were decreased when central arterial pressure monitoring was used.
描述体外循环(CPB)期间和之后的主动脉至桡动脉压力梯度,并可能导致动脉血压被低估。作者假设,与桡动脉压力监测相比,中心动脉压力监测在心脏手术期间将与较低的去甲肾上腺素需求相关。
具有倾向评分分析的观察性前瞻性队列研究。
在三级学术医院的手术室和重症监护病房(ICU)。
共纳入并分析了 286 名接受 CPB 心脏手术的连续成年患者(中央组:109 例;桡动脉组:177 例)。
为了探讨测量部位的血流动力学效应,作者根据股动脉/腋动脉(中央组)或桡动脉(桡动脉组)的动脉压力监测部位将队列分为 2 组。
主要结果是术中给予的去甲肾上腺素量。次要结果包括术后第 2 天(POD2)的去甲肾上腺素无输注时间和 ICU 无入住时间。建立了逻辑模型和倾向评分分析来预测中心动脉压力监测的使用。作者比较了调整前后的人口统计学、血流动力学和结局数据。与桡动脉组相比,中央组患者的欧洲心脏手术风险评估系统(EuroSCORE)更高-7.9±14.0 与 3.8±7.0,p<0.001。调整后,两组患者的患者 EuroSCORE 和动脉血压水平相似。术中去甲肾上腺素剂量方案分别为中央组 0.10±0.10μg/kg/min 和桡动脉组 0.11±0.11μg/kg/min(p=0.519)。POD2 的去甲肾上腺素无输注时间分别为中央组 38±17 小时和桡动脉组 33±19 小时(p=0.034)。POD2 的 ICU 无入住时间在中央组中更大:18±13 小时与 13±13 小时,p=0.008。与桡动脉组相比,中央组的不良事件发生率较低-67%与 50%,p=0.007。
在心脏手术期间,根据动脉测量部位,去甲肾上腺素剂量方案没有差异。然而,当使用中心动脉压力监测时,去甲肾上腺素的使用和 ICU 住院时间缩短,不良事件减少。